ClinicalTrials.gov record

Completed Phase 2Phase 3 Interventional Accepts healthy volunteers Results available

Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months

ClinicalTrials.gov ID: NCT00996307

Public ClinicalTrials.gov record NCT00996307. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jun 26, 2026, 5:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1) 2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months

Study identification

NCT ID: NCT00996307
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2, Phase 3
Lead sponsor: Novartis Vaccines; Industry
Enrollment: 654 participants

Conditions and interventions

Conditions

Influenza

Interventions

MF59-eH1N1_f Biological

Biological

Eligibility (public fields only)

Age range: 6 Months to 35 Months
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 30, 2009
Primary completion: Nov 30, 2009
Completion: Nov 30, 2010
Last update posted: May 29, 2017

2009 – 2010

United States locations

U.S. sites: 28
U.S. states: 14
U.S. cities: 28

Facility	City	State	ZIP	Site status
Not listed	Bentonville	Arkansas	72712	—
Not listed	Fort Smith	Arkansas	72903	—
Not listed	Canoga Park	California	91306	—
Not listed	Dinuba	California	93618	—
Not listed	Fresno	California	93703	—
Not listed	Long Beach	California	90806	—
Not listed	Los Angeles	California	90015	—
Not listed	Madera	California	93637	—
Not listed	Torrance	California	90503	—
Not listed	New Albany	Indiana	47150	—
Not listed	Newton	Kansas	67114	—
Not listed	Wichita	Kansas	67207	—
Not listed	Bardstown	Kentucky	40004	—
Not listed	Woburn	Massachusetts	01801	—
Not listed	Fargo	North Dakota	58104	—
Not listed	Dayton	Ohio	45406	—
Not listed	Huber Heights	Ohio	45424	—
Not listed	Oklahoma City	Oklahoma	73103	—
Not listed	Charleston	South Carolina	29406	—
Not listed	Spartanburg	South Carolina	29303	—
Not listed	Lebanon	Tennessee	37087	—
Not listed	Dallas	Texas	75230	—
Not listed	Houston	Texas	77055	—
Not listed	Provo	Utah	84604	—
Not listed	South Jordan	Utah	84095	—
Not listed	St. George	Utah	84790	—
Not listed	West Jordan	Utah	84088	—
Not listed	Charlottesville	Virginia	22902	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00996307, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 29, 2017 · Synced Jun 26, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00996307 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →